Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 429486, 14 pages
http://dx.doi.org/10.1155/2014/429486
Research Article

In Silico Investigation of Potential TRAF6 Inhibitor from Traditional Chinese Medicine against Cancers

1School of Pharmacy, China Medical University, Taichung 40402, Taiwan
2School of Medicine, College of Medicine, China Medical University, Taichung 40402, Taiwan
3Department of Biomedical Informatics, Asia University, Taichung 41354, Taiwan
4Department of Neurosurgery, China Medical University Hospital, Taichung 40447, Taiwan
5Research Center for Chinese Medicine & Acupuncture, China Medical University, Taichung 40402, Taiwan
6Human Genetic Center, Department of Medical Research, China Medical University Hospital, Taichung 40447, Taiwan

Received 21 February 2014; Accepted 5 March 2014; Published 25 June 2014

Academic Editor: Chung Y. Hsu

Copyright © 2014 Kuan-Chung Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Jiang, X. Li, W. Yang et al., “PKM2 regulates chromosome segregation and mitosis progression of tumor cells,” Molecular Cell, vol. 53, no. 1, pp. 75–87, 2014. View at Google Scholar
  2. Y. M. Chang, B. K. Velmurugan, W. W. Kuo et al., “Inhibitory effect of alpinate Oxyphyllae fructus extracts on Ang II-induced cardiac pathological remodeling-related pathways in H9c2 cardiomyoblast cells,” BioMedicine, vol. 3, no. 4, pp. 148–152, 2013. View at Google Scholar
  3. Y. M. Leung, K. L. Wong, S. W. Chen et al., “Down-regulation of voltage-gated Ca2+ channels in Ca2+ store-depleted rat insulinoma RINm5F cells,” BioMedicine (Netherlands), vol. 3, no. 3, pp. 130–139, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. M. A. Leissring, E. Malito, S. Hedouin et al., “Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin,” PLoS ONE, vol. 5, no. 5, article e10504, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. M. C. Lin, S. Y. Tsai, F. Y. Wang et al., “Leptin induces cell invasion and the upregulation of matrilysin in human colon cancer cells,” BioMedicine, vol. 3, no. 4, pp. 174–180, 2013. View at Google Scholar
  6. V. Janssens and J. Goris, “Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling,” Biochemical Journal, vol. 353, no. 3, pp. 417–439, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Sun, X.-B. Li, Y. Meng, L. Fan, M. Li, and J. Fang, “TRAF6 upregulates expression of HIF-1α and promotes tumor angiogenesis,” Cancer Research, vol. 73, no. 15, pp. 4950–4959, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Frede, U. Berchner-Pfannschmidt, and J. Fandrey, “Regulation of hypoxia-inducible factors during inflammation,” Methods in Enzymology, vol. 435, pp. 403–419, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. J. Chen, “Ubiquitination in signaling to and activation of IKK,” Immunological Reviews, vol. 246, no. 1, pp. 95–106, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Skaug, X. Jiang, and Z. J. Chen, “The role of ubiquitin in NF-κB regulatory pathways,” Annual Review of Biochemistry, vol. 78, pp. 769–796, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J.-I. Inoue, T. Ishida, N. Tsukamoto et al., “Tumor necrosis factor receptor-associated factor (TRAF) family: Adapter proteins that mediate cytokine signaling,” Experimental Cell Research, vol. 254, no. 1, pp. 14–24, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Choi, “Role of TRAF6 in the immune system,” Advances in Experimental Medicine and Biology, vol. 560, pp. 77–82, 2005. View at Google Scholar · View at Scopus
  13. J. R. Bradley and J. S. Pober, “Tumor necrosis factor receptor-associated factors (TRAFs),” Oncogene, vol. 20, no. 44, pp. 6482–6491, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. K. M. Arcipowski and G. A. Bishop, “Roles of the kinase TAK1 in TRAF6-dependent signaling by CD40 and its oncogenic viral mimic, LMP1,” PLoS ONE, vol. 7, no. 7, article e42478, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. B. S. Hostager, “Roles of TRAF6 in CD40 signaling,” Immunologic Research, vol. 39, no. 1–3, pp. 105–114, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. B. G. Darnay, A. Besse, A. T. Poblenz, B. Lamothe, and J. J. Jacoby, “TRAFs in RANK signaling,” Advances in Experimental Medicine and Biology, vol. 597, pp. 152–159, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. D. T. Starczynowski, F. Kuchenbauer, B. Argiropoulos et al., “Identification of miR-145 and miR-146a as mediators of the 5q-syndrome phenotype,” Nature Medicine, vol. 16, no. 1, pp. 49–58, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Beroukhim, C. H. Mermel, D. Porter et al., “The landscape of somatic copy-number alteration across human cancers,” Nature, vol. 463, no. 7283, pp. 899–905, 2010. View at Google Scholar
  19. D. T. Starczynowski, W. W. Lockwood, S. Deléhouzée et al., “TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancer,” Journal of Clinical Investigation, vol. 121, no. 10, pp. 4095–4105, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Y.-C. Chen, “A novel integrated framework and improved methodology of computer-aided drug design,” Current Topics in Medicinal Chemistry, vol. 13, no. 9, pp. 965–988, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. H.-J. Huang, H. W. Yu, C.-Y. Chen et al., “Current developments of computer-aided drug design,” Journal of the Taiwan Institute of Chemical Engineers, vol. 41, no. 6, pp. 623–635, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. C.-Y. Chen and C. Y.-C. Chen, “Insights into designing the dual-targeted HER2/HSP90 inhibitors,” Journal of Molecular Graphics and Modelling, vol. 29, no. 1, pp. 21–31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. S.-C. Yang, S.-S. Chang, H.-Y. Chen, and C. Y.-C. Chen, “Identification of potent EGFR inhibitors from TCM Database@Taiwan,” PLoS Computational Biology, vol. 7, no. 10, article e1002189, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. Y.-A. Tsou, K.-C. Chen, H.-C. Lin, S.-S. Chang, and C. Y.-C. Chen, “Uroporphyrinogen decarboxylase as a potential target for specific components of Traditional Chinese Medicine: A Virtual Screening and Molecular Dynamics Study,” PLoS ONE, vol. 7, no. 11, article e50087, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. K.-C. Chen, M.-F. Sun, S.-C. Yang et al., “Investigation into potent inflammation inhibitors from Traditional Chinese Medicine,” Chemical Biology and Drug Design, vol. 78, no. 4, pp. 679–688, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. S.-S. Chang, H.-J. Huang, and C. Y.-C. Chen, “Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine,” PLoS Computational Biology, vol. 7, no. 12, article e1002315, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. K.-C. Chen, S.-S. Chang, H.-J. Huang, T.-L. Lin, Y.-J. Wu, and C. Y.-C. Chen, “Three-in-one agonists for PPAR-a, PPAR-γ, and PPAR-d from traditional Chinese medicine,” Journal of Biomolecular Structure and Dynamics, vol. 30, no. 6, pp. 662–683, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. K. C. Chen, S. S. Chang, F. J. Tsai, and C. Y. Chen, “Han ethnicity-specific type 2 diabetic treatment from traditional Chinese medicine?” Journal of Biomolecular Structure ' Dynamics, vol. 31, no. 11, pp. 1219–1235, 2013. View at Google Scholar
  29. T.-T. Chang, K.-C. Chen, K.-W. Chang et al., “In silico pharmacology suggests ginger extracts may reduce stroke risks,” Molecular BioSystems, vol. 7, no. 9, pp. 2702–2710, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. T.-Y. Tsai, K.-W. Chang, and C. Y.-C. Chen, “IScreen: world's first cloud-computing web server for virtual screening and de novo drug design based on TCM database@Taiwan,” Journal of Computer-Aided Molecular Design, vol. 25, no. 6, pp. 525–531, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. T.-T. Chang, K.-C. Chen, K.-W. Chang et al., “In silico pharmacology suggests ginger extracts may reduce stroke risks,” Molecular BioSystems, vol. 7, no. 9, pp. 2702–2710, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. W. I. Tou, S.-S. Chang, C.-C. Lee, and C. Y.-C. Chen, “Drug design for neuropathic pain regulation from traditional Chinese medicine,” Scientific Reports, vol. 3, p. 844, 2013. View at Google Scholar · View at Scopus
  33. C. Y.-C. Chen, “A novel integrated framework and improved methodology of computer-aided drug design,” Current Topics in Medicinal Chemistry, vol. 13, no. 9, pp. 965–988, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Y.-C. Chen, “TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening In Silico,” PLoS ONE, vol. 6, no. 1, article e15939, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. W. I. Tou and C. Y. Chen, “May disordered protein cause serious drug side effect?” Drug Discovery Today, vol. 19, no. 4, pp. 367–372, 2014. View at Google Scholar
  36. C. Y.-C. Chen and W. I. Tou, “How to design a drug for the disordered proteins?” Drug Discovery Today, vol. 18, no. 19-20, pp. 910–915, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. Q. Yin, S.-C. Lin, B. Lamothe et al., “E2 interaction and dimerization in the crystal structure of TRAF6,” Nature Structural and Molecular Biology, vol. 16, no. 6, pp. 658–666, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Xue, R. L. Dunbrack, R. W. Williams, A. K. Dunker, and V. N. Uversky, “PONDR-FIT: a meta-predictor of intrinsically disordered amino acids,” Biochimica et Biophysica Acta, vol. 1804, no. 4, pp. 996–1010, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. B. R. Brooks, R. E. Bruccoleri, B. D. Olafson et al., “CHARMM: a program for macromolecular energy minimization and dynamics calculations,” Journal of Computational Chemistry, vol. 4, pp. 187–217, 1983. View at Google Scholar
  40. C. A. Lipinski, F. Lombardo, B. W. Dominy, and P. J. Feeney, “Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings,” Advanced Drug Delivery Reviews, vol. 46, no. 1–3, pp. 3–26, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. C. M. Venkatachalam, X. Jiang, T. Oldfield, and M. Waldman, “LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites,” Journal of Molecular Graphics and Modelling, vol. 21, no. 4, pp. 289–307, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. B. Hess, C. Kutzner, D. Van Der Spoel, and E. Lindahl, “GRGMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation,” Journal of Chemical Theory and Computation, vol. 4, no. 3, pp. 435–447, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. V. Zoete, M. A. Cuendet, A. Grosdidier, and O. Michielin, “SwissParam: a fast force field generation tool for small organic molecules,” Journal of Computational Chemistry, vol. 32, no. 11, pp. 2359–2368, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. R. Fletcher, Optimization, Academic Press, New York, NY, USA, 1969.
  45. E. Chovancova, A. Pavelka, P. Benes et al., “CAVER 3.0: a tool for the analysis of transport pathways in dynamic protein structures,” PLoS Computational Biology, vol. 8, no. 10, article e1002708, 2012. View at Publisher · View at Google Scholar · View at Scopus